Karpman D - Search Results

1

A common origin of the 4143insA ADAMTS13 mutation.

Schneppenheim R, Kremer Hovinga JA, Becker T, Budde U, Karpman D, Brockhaus W, Hrachovinová I, Korczowski B, Oyen F, Rittich S, von Rosen J, Tjønnfjord GE, Pimanda JE, Wienker TF, Lämmle B. Schneppenheim R, et al. Among authors: karpman d. Thromb Haemost. 2006 Jul;96(1):3-6. doi: 10.1160/TH05-12-0817. Thromb Haemost. 2006. PMID: 16807643

2

Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura.

Manea M, Kristoffersson A, Schneppenheim R, Saleem MA, Mathieson PW, Mörgelin M, Björk P, Holmberg L, Karpman D. Manea M, et al. Among authors: karpman d. Br J Haematol. 2007 Sep;138(5):651-62. doi: 10.1111/j.1365-2141.2007.06694.x. Epub 2007 Jul 12. Br J Haematol. 2007. PMID: 17627784 Free article.

3

Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand's disease.

Holmberg L, Karpman D, Isaksson C, Kristoffersson AC, Lethagen S, Schneppenheim R. Holmberg L, et al. Among authors: karpman d. Thromb Haemost. 1998 Apr;79(4):718-22. Thromb Haemost. 1998. PMID: 9569179

4

von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura.

Karpman D, Lethagen S, Kristoffersson A, Isaksson C, Holmberg L. Karpman D, et al. Thromb Haemost. 1997 Dec;78(6):1456-62. Thromb Haemost. 1997. PMID: 9423794

5

Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency.

Assink K, Schiphorst R, Allford S, Karpman D, Etzioni A, Brichard B, van de Kar N, Monnens L, van den Heuvel L. Assink K, et al. Among authors: karpman d. Kidney Int. 2003 Jun;63(6):1995-9. doi: 10.1046/j.1523-1755.63.6s.1.x. Kidney Int. 2003. PMID: 12753286 Free article.

6

ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.

Manea M, Kristoffersson A, Tsai HM, Zhou W, Winqvist I, Oldaeus G, Billström R, Björk P, Holmberg L, Karpman D. Manea M, et al. Among authors: karpman d. Eur J Pediatr. 2007 Mar;166(3):249-57. doi: 10.1007/s00431-006-0354-2. Epub 2006 Dec 24. Eur J Pediatr. 2007. PMID: 17187257 Free PMC article.

7

Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.

Manea M, Karpman D. Manea M, et al. Among authors: karpman d. Pediatr Nephrol. 2009 Mar;24(3):447-58. doi: 10.1007/s00467-008-0986-8. Epub 2008 Sep 20. Pediatr Nephrol. 2009. PMID: 18807073 Review.

8

Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy.

Tati R, Kristoffersson AC, Ståhl AL, Rebetz J, Wang L, Licht C, Motto D, Karpman D. Tati R, et al. Among authors: karpman d. J Immunol. 2013 Sep 1;191(5):2184-93. doi: 10.4049/jimmunol.1301221. Epub 2013 Jul 22. J Immunol. 2013. PMID: 23878316 Free PMC article.

9

Platelet activation in hemolytic uremic syndrome.

Karpman D, Manea M, Vaziri-Sani F, Ståhl AL, Kristoffersson AC. Karpman D, et al. Semin Thromb Hemost. 2006 Mar;32(2):128-45. doi: 10.1055/s-2006-939769. Semin Thromb Hemost. 2006. PMID: 16575688 Review.

10

Biologically active ADAMTS13 is expressed in renal tubular epithelial cells.

Manea M, Tati R, Karlsson J, Békássy ZD, Karpman D. Manea M, et al. Among authors: karpman d. Pediatr Nephrol. 2010 Jan;25(1):87-96. doi: 10.1007/s00467-009-1262-2. Pediatr Nephrol. 2010. PMID: 19644711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page